Adaptation of the Australian Palliative Care Phase concept to the German palliative care context: a mixed-methods approach using cognitive interviews and cross-sectional data.

Cognitive interviewing Inter-rater reliability Outcome measurement Palliative care Palliative care phases Quality of healthcare Reproducibility of results

Journal

BMC palliative care
ISSN: 1472-684X
Titre abrégé: BMC Palliat Care
Pays: England
ID NLM: 101088685

Informations de publication

Date de publication:
14 Aug 2021
Historique:
received: 15 04 2021
accepted: 24 07 2021
entrez: 15 8 2021
pubmed: 16 8 2021
medline: 16 10 2021
Statut: epublish

Résumé

Palliative care phases (stable, unstable, deteriorating, terminal and bereavement) are routinely used in Australia and the UK to describe the clinical situation of patients and their families and to evaluate the associated care plan. In addition, it serves as a benchmark developed by the Australian Palliative Care Outcome Collaboration (PCOC) and is used nationwide for comparisons between services. In Germany, the concept is not used consistently due to various translations. Furthermore, there is no nationwide systematic approach to routinely assess clinical outcomes in palliative care. The study aims to develop a German version of the palliative care phase definitions by adapting them culturally, and to examine the inter-rater reliability of the adjusted definitions with healthcare professionals. Mixed-methods approach: Cognitive interview study using 'think aloud' and verbal probing techniques and a consecutive multi-center cross-sectional study with two clinicians independently assigning the phase definitions. Interviewees/participants were selected through convenience and purposive sampling in specialist palliative care inpatient units, advisory and community services and in three specialist palliative care units with doctors, nursing staff and allied health professionals. Fifteen interviews were conducted. Identified difficulties were: Some translated terms were 1) not self-explanatory (e.g. 'family/carer' or 'care plan') and (2) too limited to the medical dimension neglecting the holistic approach of palliative care. (3) Problems of comprehension regarding the concept in general occurred, e.g. in differentiating between the 'unstable' and 'deteriorating' phase. Inter-rater reliability was moderate (kappa = 0.44; 95% CI = 0.39-0.52). The assignment of the phase 'deteriorating' has caused the most difficulties. Overall, the adapted palliative care phases are suitable to use in the German specialist palliative care setting. However, the concept of the phases is not self-explanatory. To implement it nationwide for outcome measurement/benchmarking, it requires further education, on-the-job training and experience as well as the involvement of healthcare professionals in implementation process. For the use of international concepts in different healthcare systems, a deeper discussion and cultural adaptation is necessary besides the formal translation.

Sections du résumé

BACKGROUND BACKGROUND
Palliative care phases (stable, unstable, deteriorating, terminal and bereavement) are routinely used in Australia and the UK to describe the clinical situation of patients and their families and to evaluate the associated care plan. In addition, it serves as a benchmark developed by the Australian Palliative Care Outcome Collaboration (PCOC) and is used nationwide for comparisons between services. In Germany, the concept is not used consistently due to various translations. Furthermore, there is no nationwide systematic approach to routinely assess clinical outcomes in palliative care. The study aims to develop a German version of the palliative care phase definitions by adapting them culturally, and to examine the inter-rater reliability of the adjusted definitions with healthcare professionals.
METHODS METHODS
Mixed-methods approach: Cognitive interview study using 'think aloud' and verbal probing techniques and a consecutive multi-center cross-sectional study with two clinicians independently assigning the phase definitions. Interviewees/participants were selected through convenience and purposive sampling in specialist palliative care inpatient units, advisory and community services and in three specialist palliative care units with doctors, nursing staff and allied health professionals.
RESULTS RESULTS
Fifteen interviews were conducted. Identified difficulties were: Some translated terms were 1) not self-explanatory (e.g. 'family/carer' or 'care plan') and (2) too limited to the medical dimension neglecting the holistic approach of palliative care. (3) Problems of comprehension regarding the concept in general occurred, e.g. in differentiating between the 'unstable' and 'deteriorating' phase. Inter-rater reliability was moderate (kappa = 0.44; 95% CI = 0.39-0.52). The assignment of the phase 'deteriorating' has caused the most difficulties.
CONCLUSION CONCLUSIONS
Overall, the adapted palliative care phases are suitable to use in the German specialist palliative care setting. However, the concept of the phases is not self-explanatory. To implement it nationwide for outcome measurement/benchmarking, it requires further education, on-the-job training and experience as well as the involvement of healthcare professionals in implementation process. For the use of international concepts in different healthcare systems, a deeper discussion and cultural adaptation is necessary besides the formal translation.

Identifiants

pubmed: 34391419
doi: 10.1186/s12904-021-00825-z
pii: 10.1186/s12904-021-00825-z
pmc: PMC8364299
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

128

Informations de copyright

© 2021. The Author(s).

Références

Home Healthc Nurse. 2011 Mar;29(3):139-45; quiz 146-7
pubmed: 21368625
Res Nurs Health. 2007 Apr;30(2):224-34
pubmed: 17380524
Spine (Phila Pa 1976). 2000 Dec 15;25(24):3186-91
pubmed: 11124735
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
Curr Treat Options Oncol. 2020 Feb 5;21(2):12
pubmed: 32025964
J Pain Symptom Manage. 2015 Mar;49(3):611-24
pubmed: 25135657
J Clin Oncol. 2008 Aug 10;26(23):3853-9
pubmed: 18688052
Palliat Med. 2018 Apr;32(4):804-814
pubmed: 29130380
Palliat Med. 2018 Feb;32(2):404-412
pubmed: 28812945
J Pain Symptom Manage. 2016 Aug;52(2):292-7
pubmed: 27090851
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
Palliat Med. 2014 Feb;28(2):158-75
pubmed: 23801463
J Palliat Med. 2018 Jan;21(S1):S76-S80
pubmed: 29283866
Palliat Med. 2021 Feb;35(2):397-407
pubmed: 33249996
BMJ Open. 2018 Mar 17;8(3):e020071
pubmed: 29550781
Palliat Med. 2004 Apr;18(3):217-26
pubmed: 15198134
Palliat Med. 2004 Apr;18(3):227-33
pubmed: 15198135
Palliat Med. 2021 May;35(5):962-971
pubmed: 33863246
Palliat Med. 2015 Jan;29(1):22-30
pubmed: 25249239
Support Care Cancer. 2015 Feb;23(2):307-15
pubmed: 25063272
Palliat Med. 2019 Sep;33(8):1058-1068
pubmed: 31185812
BMC Health Serv Res. 2019 Mar 12;19(1):157
pubmed: 30866912
Ann Palliat Med. 2018 Oct;7(Suppl 3):S137-S150
pubmed: 30339764
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
Int J Palliat Nurs. 2002 Nov;8(11):540-7
pubmed: 12514464

Auteurs

Eva Lehmann (E)

Department, of Palliative Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. eva.lehmann@med.uni-muenchen.de.

Farina Hodiamont (F)

Department, of Palliative Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Mirjam Landmesser (M)

Department of Palliative Medicine, University Medical Center Goettingen, Goettingen, Germany.

Carina S Knobloch (CS)

Department of Palliative Medicine, Universitätsklinikum Erlangen, CCC Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Friedemann Nauck (F)

Department of Palliative Medicine, University Medical Center Goettingen, Goettingen, Germany.

Christoph Ostgathe (C)

Department of Palliative Medicine, Universitätsklinikum Erlangen, CCC Erlangen-EMN, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.

Bettina Grüne (B)

Department, of Palliative Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Claudia Bausewein (C)

Department, of Palliative Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH